Welcome to Antipsychotic-Induced Weight Gain and Metabolic Syndrome (MetS) Course.
Obesity and metabolic syndrome (MetS) are critical public health problems that can result in cardiovascular disease and type 2 diabetes. Obesity and MetS are more prevalent in people with a mental illness, especially patients taking antipsychotic medications.
Weight gain and metabolic dysfunction due to antipsychotic medication are associated with significant physical and psychological morbidity.
This course should take approximately 2.5 hours for you to complete going through the following journey:
Throughout this course, we will:
- Consider the role antipsychotics play in the development of metabolic syndrome
- Determine the mechanisms of antipsychotic-associated weight gain
- Explore the complexities of antipsychotics according to their risk of metabolic dysfunction
- Develop strategies for the management of antipsychotic-associated weight gain from a pharmacological and non-pharmacological perspective.
- Discuss the role antipsychotics play in the development of type 2 diabetes mellitus (T2DM).
- Discuss treatment options in Type 2 DM relevant to psychiatrists.
